Mittal Setu, Khaitan Binod K, Ramam M, Khanna Neena, Mahajan Rahul, Bhalla Ashu Seith, Singh Manoj K, Sreenivas V
From the Department of Dermatology, Mayo Clinic, Rochester, MN, USA.
Department of Dermatology and Venereology, AIIMS, New Delhi, India.
Indian J Dermatol. 2024 Jul-Aug;69(4):365. doi: 10.4103/ijd.ijd_251_24. Epub 2024 Aug 19.
Pigmentary changes of the skin in systemic sclerosis in the form of diffuse hyperpigmentation and salt-and-pepper pigmentation are well documented in the literature; however, its association with disease severity and extent of underlying internal organ involvement has not been well studied.
To assess the correlation between morphology and extent of pigmentary changes with the degree of cutaneous sclerosis and frequency and degree of major organ involvement.
This was a cross-sectional descriptive study conducted in a tertiary care teaching hospital from December 2014 to November 2016. Consecutive patients of systemic sclerosis attending the outpatient department were screened, and patients satisfying the diagnosis as per the American Rheumatism Association criteria were recruited. Skin sclerosis was quantified using modified Rodnan skin score (MRSS), whereas pigmentary changes were calculated in terms of percentage of body surface area involved by rule-of-nine method. Investigations were carried out depending on organ involvement and as per respective specialty consultations with focus on pulmonary, cardiac, and gastrointestinal systems.
Of the 50 patients recruited, all had cutaneous involvement in the form of binding down of skin, followed by pigmentary changes. MRSS was significantly higher in patients with any pigmentary alteration ( = 0.03) compared to those without any pigmentary changes. There was a rising trend in between the MRSS severity and the proportion of patients with hyperpigmentation, and it was statistically significant ( = 0.04). Among systemic involvement, lung was involved in the form of interstitial lung disease in 94% patients (n = 47). However, skin pigmentation of any type was associated with lower high-resolution computed tomography scores ( = 0.02).
This study shows that in systemic sclerosis patients presenting with pigmentary skin manifestations, cutaneous sclerosis is significantly higher.
系统性硬化症患者皮肤色素沉着改变,表现为弥漫性色素沉着过度和椒盐样色素沉着,在文献中有充分记载;然而,其与疾病严重程度及潜在内脏器官受累程度的关联尚未得到充分研究。
评估色素沉着改变的形态和范围与皮肤硬化程度以及主要器官受累频率和程度之间的相关性。
这是一项于2014年12月至2016年11月在一家三级护理教学医院开展的横断面描述性研究。对门诊就诊的系统性硬化症连续患者进行筛查,招募符合美国风湿病协会标准诊断的患者。使用改良罗德南皮肤评分(MRSS)对皮肤硬化进行量化,而色素沉着改变则采用九分法计算受累体表面积的百分比。根据器官受累情况并按照各专科会诊意见进行检查,重点关注肺、心脏和胃肠道系统。
在招募的50例患者中,所有患者均有皮肤受累,表现为皮肤紧绷,其次是色素沉着改变。与无任何色素沉着改变的患者相比,有任何色素沉着改变的患者MRSS显著更高(P = 0.03)。MRSS严重程度与色素沉着过度患者比例之间呈上升趋势,且具有统计学意义(P = 0.04)。在系统性受累方面,94%的患者(n = 47)以间质性肺病的形式累及肺部。然而,任何类型的皮肤色素沉着与较低的高分辨率计算机断层扫描评分相关(P = 0.02)。
本研究表明,在出现皮肤色素沉着表现的系统性硬化症患者中,皮肤硬化程度显著更高。